TWD 41.9
(-1.53%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 269.22 Million TWD | 201.46% |
2022 | 89.3 Million TWD | -11.26% |
2021 | 100.64 Million TWD | -7.04% |
2020 | 108.25 Million TWD | -53.25% |
2019 | 231.58 Million TWD | 0.7% |
2018 | 229.97 Million TWD | -95.54% |
2017 | 5.15 Billion TWD | 34.41% |
2016 | 3.83 Billion TWD | 25.18% |
2015 | 3.06 Billion TWD | 2308.88% |
2014 | 127.1 Million TWD | 43.48% |
2013 | 88.59 Million TWD | -9.84% |
2012 | 98.25 Million TWD | 56.61% |
2011 | 62.74 Million TWD | 2.2% |
2010 | 61.39 Million TWD | 32.76% |
2009 | 46.24 Million TWD | 21.55% |
2008 | 38.04 Million TWD | 89.2% |
2007 | 20.1 Million TWD | 8.99% |
2006 | 18.45 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 270.4 Million TWD | 0.44% |
2024 Q2 | 272.67 Million TWD | 0.84% |
2023 Q1 | 190.51 Million TWD | 113.33% |
2023 Q3 | 252.3 Million TWD | 14.96% |
2023 Q4 | 269.22 Million TWD | 6.71% |
2023 FY | 269.22 Million TWD | 201.46% |
2023 Q2 | 219.48 Million TWD | 15.2% |
2022 Q2 | 74.51 Million TWD | -16.77% |
2022 Q4 | 89.3 Million TWD | 16.59% |
2022 FY | 89.3 Million TWD | -11.26% |
2022 Q1 | 89.53 Million TWD | -11.04% |
2022 Q3 | 76.6 Million TWD | 2.8% |
2021 Q4 | 100.64 Million TWD | 1.02% |
2021 FY | 100.64 Million TWD | -7.04% |
2021 Q1 | 103.32 Million TWD | -4.55% |
2021 Q2 | 108.15 Million TWD | 4.67% |
2021 Q3 | 99.62 Million TWD | -7.89% |
2020 Q3 | 96.08 Million TWD | -0.31% |
2020 Q4 | 108.25 Million TWD | 12.67% |
2020 Q2 | 96.38 Million TWD | -59.16% |
2020 Q1 | 235.99 Million TWD | 1.9% |
2020 FY | 108.25 Million TWD | -53.25% |
2019 FY | 231.58 Million TWD | 0.7% |
2019 Q3 | 233.55 Million TWD | 4.69% |
2019 Q2 | 223.09 Million TWD | -6.19% |
2019 Q1 | 237.81 Million TWD | 3.41% |
2019 Q4 | 231.58 Million TWD | -0.84% |
2018 Q2 | 212.87 Million TWD | -96.54% |
2018 Q1 | 6.14 Billion TWD | 19.36% |
2018 FY | 229.97 Million TWD | -95.54% |
2018 Q4 | 229.97 Million TWD | 16.95% |
2018 Q3 | 196.64 Million TWD | -7.62% |
2017 Q3 | 5.02 Billion TWD | 10.99% |
2017 Q2 | 4.52 Billion TWD | 16.37% |
2017 Q1 | 3.88 Billion TWD | 1.4% |
2017 FY | 5.15 Billion TWD | 34.41% |
2017 Q4 | 5.15 Billion TWD | 2.62% |
2016 Q3 | 4.25 Billion TWD | 1.54% |
2016 FY | 3.83 Billion TWD | 25.18% |
2016 Q1 | 3.74 Billion TWD | 22.32% |
2016 Q2 | 4.19 Billion TWD | 11.92% |
2016 Q4 | 3.83 Billion TWD | -9.95% |
2015 Q4 | 3.06 Billion TWD | -3.66% |
2015 FY | 3.06 Billion TWD | 2308.88% |
2015 Q3 | 3.17 Billion TWD | 1721.23% |
2015 Q2 | 174.51 Million TWD | 9.97% |
2015 Q1 | 158.68 Million TWD | 24.84% |
2014 Q1 | 96.19 Million TWD | 8.58% |
2014 FY | 127.1 Million TWD | 43.48% |
2014 Q4 | 127.1 Million TWD | 10.68% |
2014 Q3 | 114.84 Million TWD | 2.13% |
2014 Q2 | 112.44 Million TWD | 16.9% |
2013 Q2 | 98.41 Million TWD | 1.93% |
2013 Q3 | 90.72 Million TWD | -7.81% |
2013 FY | 88.59 Million TWD | -9.84% |
2013 Q4 | 88.59 Million TWD | -2.35% |
2013 Q1 | 96.54 Million TWD | -1.74% |
2012 Q2 | 72.34 Million TWD | 12.11% |
2012 Q4 | 98.25 Million TWD | 22.25% |
2012 Q3 | 80.37 Million TWD | 11.1% |
2012 Q1 | 64.52 Million TWD | 2.85% |
2012 FY | 98.25 Million TWD | 56.61% |
2011 Q3 | 70.06 Million TWD | 5.64% |
2011 Q1 | 68.13 Million TWD | 10.98% |
2011 Q2 | 66.32 Million TWD | -2.65% |
2011 Q4 | 62.74 Million TWD | -10.46% |
2011 FY | 62.74 Million TWD | 2.2% |
2010 FY | 61.39 Million TWD | 32.76% |
2010 Q4 | 61.39 Million TWD | 0.0% |
2009 FY | 46.24 Million TWD | 21.55% |
2008 FY | 38.04 Million TWD | 89.2% |
2007 FY | 20.1 Million TWD | 8.99% |
2006 FY | 18.45 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 55.239% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | -73.21% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -538.42% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 75.434% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 83.155% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 75.431% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -255.201% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | -15.068% |
InnoPharmax Inc. | 22.24 Million TWD | -1110.394% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | -93.959% |
Excelsior Biopharma Inc. | 217.28 Million TWD | -23.908% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -178.949% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -112.327% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -830.169% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 5.155% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -132.623% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -2572.503% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -381.194% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -127.398% |